指南与共识其他结缔组织病

2016 ACR/EULAR 原发性干燥综合征分类标准

2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.
指南 / 共识 · Ann Rheum Dis · 2016-10-26

该标准由 ACR 与 EULAR 支持制定,用于有干燥综合征(SS)相关症状者。基于五个项目加权总分≥4 分类为原发性 SS,验证队列敏感度 96%、特异度 95%。

要点

  • 抗 SSA/Ro 抗体阳性与灶性淋巴细胞性涎腺炎(灶评分≥1 灶/4 mm²)各计 3 分。
  • 眼染色评分≥5(或 van Bijsterveld 评分≥4)、Schirmer 试验≤5 mm/5 min、非刺激唾液流率≤0.1 mL/min 各计 1 分。
  • 有疑似 SS 症状者五项总分≥4 分即符合原发性 SS 分类标准。

核心结论

  • 建立了数据驱动的原发性 SS 分类标准,在验证分析中表现良好,适合作为临床试验入组标准。

研究设计与样本

  • 采用多准则决策分析对候选项目赋初步权重,用已有原发性 SS 病例与非 SS 对照队列数据(病例状态由专家临床判断确定)测试并修订草案标准,再在独立患者队列中验证性能。

主要发现

  • 最终分类标准基于五个项目的加权总分,总分≥4 分即符合原发性 SS 分类标准。
  • 在最终验证队列中,与临床专家判断的病例/非病例状态相比,敏感度为 96%(95%CI 92%~98%),特异度为 95%(95%CI 92%~97%)。

关键数值与推荐

  • 抗 SSA/Ro 抗体阳性计 3 分;灶性淋巴细胞性涎腺炎且灶评分≥1 灶/4 mm² 计 3 分。
  • 异常眼染色评分≥5(或 van Bijsterveld 评分≥4)计 1 分;Schirmer 试验结果≤5 mm/5 min 计 1 分;非刺激唾液流率≤0.1 mL/min 计 1 分。
  • 有疑似 SS 体征和/或症状者,上述项目总分≥4 分即符合原发性 SS 分类标准。

临床怎么用

  • 对具有疑似 SS 体征和/或症状的个体,可按五项加权总分≥4 分进行原发性 SS 分类。
  • 该标准适用于临床试验入组筛选,验证队列中敏感度 96%、特异度 95%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To develop and validate an international set of classification criteria for primary Sjögren's syndrome (SS) using guidelines from the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR). These criteria were developed for use in individuals with signs and/or symptoms suggestive of SS. METHODS: We assigned preliminary importance weights to a consensus list of candidate criteria items, using multi-criteria decision analysis. We tested and adapted the resulting draft criteria using existing cohort data on primary SS cases and non-SS controls, with case/non-case status derived from expert clinical judgement. We then validated the performance of the classification criteria in a separate cohort of patients. RESULTS: The final classification criteria are based on the weighted sum of five items: anti-SSA/Ro antibody positivity and focal lymphocytic sialadenitis with a focus score of ≥1 foci/4 mm2, each scoring 3; an abnormal Ocular Staining Score of ≥5 (or van Bijsterveld score of ≥4), a Schirmer's test result of ≤5 mm/5 min and an unstimulated salivary flow rate of ≤0.1 mL/min, each scoring 1. Individuals with signs and/or symptoms suggestive of SS who have a total score of ≥4 for the above items meet the criteria for primary SS. Sensitivity and specificity against clinician-expert-derived case/non-case status in the final validation cohort were high, that is, 96% (95% CI92% to 98%) and 95% (95% CI 92% to 97%), respectively. CONCLUSION: Using methodology consistent with other recent ACR/EULAR-approved classification criteria, we developed a single set of data-driven consensus classification criteria for primary SS, which performed well in validation analyses and are well suited as criteria for enrolment in clinical trials.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2016. PMID: 27789466. doi:10.1136/annrheumdis-2016-210571

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。